Compare GSK plc (GSK) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Nebius Group NV — how do they compare? GSK plc trades at $52.7 (market cap $101.34B), while Nebius Group NV trades at $174.55 (market cap $50.66B). The key difference: GSK plc is far larger — about 2× Nebius Group NV's market cap, and GSK plc pays a 3.49% dividend while Nebius Group NV pays none. Which is the better fit depends on your goals.
| GSK | NBIS | |
|---|---|---|
Market Cap | $101.34B | $50.66B |
Sector | Health | Technology |
52-Week High | $61.18 | $286.69 |
52-Week Low | $36.20 | $50.40 |
Enterprise Value | $121.95B | $50.85B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NBIS trades at $171.75, down 11.46% over 24 hours amid broader tech sector volatility. The stock shows bearish technical signals with support at $174 and resistance at $197. Fundamentally, the company reported Q1 2026 EPS of -$0.23, beating expectations, while Q4 2025 missed. Revenue grew to $529.8M in 2025 with a strong net income margin of 93.09%. Recent news highlights a $1B compute deal with Reflection AI and positive analyst coverage despite recent price pressure.
Outlook remains positive with 87.5% analyst buy ratings and a $248 consensus price target, implying 44% upside. Key risks include competitive pressures from Meta's cloud capacity and high valuation multiples (P/E 77). The company's expansion into AI infrastructure and partnerships supports long-term growth, but investors should monitor execution on capacity build-out and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
